Amundi’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Amundi's GILD Position: Q3 2026 in Review
Amundi increased its Gilead Sciences (GILD) stake by 15% in Q3 2026, buying an estimated $209M and bringing the position to 11,259,657 shares worth $1.68B. The position accounts for 0.34% of the portfolio, ranked #53.
Amundi first reported a position in GILD in Q2 2021 and has held it in 22 quarters since. 2,318 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Amundi held 11,259,657 shares of Gilead Sciences worth $1.68B as of Q3 2026.
- Amundi bought 1,487,219 Gilead Sciences shares in Q3 2026, an estimated $209M.
- Gilead Sciences made up 0.34% of Amundi's portfolio in Q3 2026, its #53 holding.
- Amundi first reported a position in Gilead Sciences in Q2 2021 and has held it in 22 quarters since.
- 2,318 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Amundi's 13F filing for Q3 2026, filed 6 Nov 2026.